Accessibility Menu
Ecs Botanics logo

Ecs Botanics(ASX) ECS

Market CapA$8.01MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2019)-92%
5 Year-85%
1 Year-38%
1 Month+0%
A$0.01
+0.00%
+0.00Today
Ecs Botanics last closing stock price
MetricPriceDate
Last closeAUD 0.012026-08-13
Ecs Botanics stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-16.67%AUD 0.012026-08-06
1 month+0%AUD 0.012026-07-14
3 month-16.67%AUD 0.012026-05-15
Year to date-16.67%AUD 0.012025-12-31
1 year-37.5%AUD 0.012025-08-13
3 year-79.17%AUD 0.022023-08-14
5 year-84.85%AUD 0.032021-08-13
Since inception-92.31%AUD 0.072019-07-22

Ecs Botanics Financials at a Glance

Market Cap

A$8.01MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$39.45M

Net Income (TTM)

-A$5.90M

EPS (TTM)

-A$0.00

P/E Ratio

-1.43

Dividend

A$0.00

Beta (Volatility)

0.18 (Low)

Price

A$0.01

Volume

0

Open

A$0.01

Previous Close

A$0.01

Daily Range

A$0.01 - A$0.01

52-Week Range

A$0.00 - A$0.01

Estimated Earnings Date

Sep 1, 2026

ECS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ecs Botanics

ECS Botanics Holdings Ltd specializes in the cultivation, processing, and commercialization of medicinal cannabis products. The company also markets a variety of hemp-derived wellness and food items, with its primary operations based in Launceston, Australia.

Products and Services
  • Medicinal cannabis cultivation and processing
  • Hemp-derived wellness and food products
  • Active participation in the agricultural sector
Growth Outlook
  • Recent revenue of AUD 11.34 million indicates strong market demand
  • Quarterly gross profit margin improved to -4.17% from previous periods
  • Expansion plans in the medicinal cannabis sector are underway
Financial Highlights
  • Trailing twelve months (TTM) revenue of AUD 36.5 million
  • Current ratio of 3.51 suggests strong liquidity position
  • Net income for the latest quarter was AUD -833,562, reflecting ongoing investment
ECS Botanics Holdings Ltd is positioned in a rapidly growing industry, focusing on medicinal cannabis and hemp products. The recent revenue figures highlight the company's potential to capitalize on increasing consumer interest in wellness products. The improvement in gross profit margin, despite being negative, indicates a trend towards better operational efficiency. The strong current ratio suggests that the company is well-equipped to meet its short-term obligations, which is crucial for sustaining growth. The ongoing investments, as reflected in the net income, are aimed at expanding operations and enhancing product offerings, which could lead to future profitability. Overall, ECS Botanics Holdings Ltd presents an intriguing opportunity within the healthcare sector, particularly for those interested in the evolving landscape of medicinal cannabis.
AI Generated • Aug 5, 2026

Industry

Pharmaceuticals

CEO

Nan-Maree Schoerie

Headquarters

Launceston, TAS 7302, AU

ECS Financials

Key Financial Metrics (TTM)

Gross Margin

13.25%

Operating Margin

-31.97%

Net Income Margin

-21.87%

Return on Equity

-19.79%

Return on Capital

-29.25%

Return on Assets

-13.97%

Earnings Yield

-69.93%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$8.01MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.60B

Volume

0

Avg. Volume

1.15M

Financials (TTM)

Gross Profit

A$8.55M

Operating Income

-A$8.14M

EBITDA

-A$2.73M

Operating Cash Flow

-A$6.62M

Capital Expenditure

-A$6.05M

Free Cash Flow

-A$12.67M

Cash & ST Invst.

A$1.31M

Total Debt

A$10.24M

Ecs Botanics Performance Analysis

Ecs Botanics annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-06-30AUD 5,298,588N/A
20232023-06-30AUD 15,388,929190.4%
20242024-06-30AUD 20,030,35630.2%
20252025-06-30AUD 19,363,143-3.3%
Ecs Botanics sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-30-22.5%
Q22024-12-3111.3%
Q42025-06-30-1.1%
Q22025-12-3117.8%
Ecs Botanics annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-06-30AUD -0.00N/A
20232023-06-30AUD 0.00N/A
20242024-06-30AUD 0.00700.0%
20252025-06-30AUD -0.00N/A
Ecs Botanics sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-30-45.5%
Q22024-12-31-350.0%
Q42025-06-30-93.3%
Q22025-12-31120.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

A$11.34M

+0.5%

Gross Profit

-A$472.71K

+70.3%

Gross Margin

-4.17%

N/A

Market Cap

A$8.01MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$36.39K

N/A

Employees

220

N/A

Net Income

-A$833.56K

-166.8%

EBITDA

-A$1.78M

-192.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

A$1.31M

-69.8%

Total Debt

A$10.24M

+1136.1%

Accounts Receivable

A$2.79M

-22.3%

Inventory

A$14.89M

+43.9%

Long Term Debt

A$7.26M

+1019.2%

Short Term Debt

A$2.98M

+728.5%

Return on Assets

-13.97%

N/A

Return on Invested Capital

-24.53%

N/A

Free Cash Flow

-A$604.20K

-32.7%

Operating Cash Flow

A$359.74K

-14.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
TRU.AXTruScreen Group Limited
A$0.01+0.00%
IXC.AXInvex Therapeutics Ltd
A$0.12+0.00%
HIQ.AXHITIQ Limited
A$0.01+0.00%
PER.AXPercheron Therapeutics Limited
A$0.01+11.11%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$8.91-0.09%
SMCISuper Micro Computer
$39.16+0.04%
SPCXSpace Exploration Technologies
$141.29-0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.64+0.07%

Questions About ECS

What is the current price of Ecs Botanics?

Ecs Botanics is trading at A$0.01 per share.

What is the 52-week range for Ecs Botanics?

Over the past 52 weeks, Ecs Botanics has traded between A$0.00 and A$0.01.

How much debt does Ecs Botanics have?

As of the most recent reporting period, Ecs Botanics reported total debt of A$6.88M.

How much cash does Ecs Botanics have on hand?

Ecs Botanics reported A$373.60K in cash and cash equivalents in its most recent financial results.

What is Ecs Botanics’s dividend yield?

Ecs Botanics does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.